← Evidence map

TrialJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2022

Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.

Russell Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2021
2022
2023
2024
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 34283019